240 related articles for article (PubMed ID: 23996575)
1. Head and neck squamous cell carcinoma of unknown primary: neck dissection and radiotherapy or definitive radiotherapy.
Demiroz C; Vainshtein JM; Koukourakis GV; Gutfeld O; Prince ME; Bradford CR; Wolf GT; McLean S; Worden FP; Chepeha DB; Schipper MJ; McHugh JB
Head Neck; 2014 Nov; 36(11):1589-1595. PubMed ID: 23996575
[TBL] [Abstract][Full Text] [Related]
2. HPV status in unknown primary head and neck cancer: Prognosis and treatment outcomes.
Cheraghlou S; Torabi SJ; Husain ZA; Otremba MD; Osborn HA; Mehra S; Yarbrough WG; Burtness BA; Judson BL
Laryngoscope; 2019 Mar; 129(3):684-691. PubMed ID: 30151832
[TBL] [Abstract][Full Text] [Related]
3. Neck dissection for unknown cancer of the head and neck in the era of chemoradiation.
Amsbaugh MJ; Yusuf M; Gaskins J; Silverman C; Potts K; Bumpous J; Redman R; Perez C; Dunlap N
Am J Otolaryngol; 2017; 38(5):588-592. PubMed ID: 28633765
[TBL] [Abstract][Full Text] [Related]
4. Neck dissection in the combined-modality therapy of patients with locoregionally advanced head and neck cancer.
Argiris A; Stenson KM; Brockstein BE; Mittal BB; Pelzer H; Kies MS; Jayaram P; Portugal L; Wenig BL; Rosen FR; Haraf DJ; Vokes EE
Head Neck; 2004 May; 26(5):447-55. PubMed ID: 15122662
[TBL] [Abstract][Full Text] [Related]
5. Treatment of squamous cell carcinoma of external auditory canal: A tertiary cancer centre experience.
Gandhi AK; Roy S; Biswas A; Raza MW; Saxena T; Bhasker S; Sharma A; Thakar A; Mohanti BK
Auris Nasus Larynx; 2016 Feb; 43(1):45-9. PubMed ID: 26165629
[TBL] [Abstract][Full Text] [Related]
6. Squamous cell carcinoma of cervical lymph nodes from an unknown primary site: The impact of neck dissection.
Lou J; Wang S; Wang K; Chen C; Zhao J; Guo L
J Cancer Res Ther; 2015 Oct; 11 Suppl 2():C161-7. PubMed ID: 26506869
[TBL] [Abstract][Full Text] [Related]
7. Relevance of the time interval between surgery and adjuvant radio (chemo) therapy in HPV-negative and advanced head and neck carcinoma of unknown primary (CUP).
Balk M; Rupp R; Mantsopoulos K; Allner M; Grundtner P; Mueller SK; Traxdorf M; Eckstein M; Speer S; Semrau S; Fietkau R; Iro H; Hecht M; Gostian AO
BMC Cancer; 2021 Nov; 21(1):1236. PubMed ID: 34794411
[TBL] [Abstract][Full Text] [Related]
8. p16-positive lymph node metastases from cutaneous head and neck squamous cell carcinoma: No association with high-risk human papillomavirus or prognosis and implications for the workup of the unknown primary.
McDowell LJ; Young RJ; Johnston ML; Tan TJ; Kleid S; Liu CS; Bressel M; Estall V; Rischin D; Solomon B; Corry J
Cancer; 2016 Apr; 122(8):1201-8. PubMed ID: 26881928
[TBL] [Abstract][Full Text] [Related]
9. p16 expression in carcinoma of unknown primary: diagnostic indicator and prognostic marker.
Vent J; Haidle B; Wedemeyer I; Huebbers C; Siefer O; Semrau R; Preuss SF; Klussmann J
Head Neck; 2013 Nov; 35(11):1521-6. PubMed ID: 23345170
[TBL] [Abstract][Full Text] [Related]
10. Association of Disease Recurrence With Survival Outcomes in Patients With Cutaneous Squamous Cell Carcinoma of the Head and Neck Treated With Multimodality Therapy.
Sun L; Chin RI; Gastman B; Thorstad W; Yom SS; Reddy CA; Nussenbaum B; Wang SJ; Knackstedt T; Vidimos AT; Koyfman SA; Manyam BV
JAMA Dermatol; 2019 Apr; 155(4):442-447. PubMed ID: 30810715
[TBL] [Abstract][Full Text] [Related]
11. Squamous cell carcinoma of unknown primary of the head and neck: Favorable prognostic factors comparable to those in oropharyngeal cancer.
Zhou MJ; van Zante A; Lazar AA; Groppo ER; Garsa AA; Ryan WR; El-Sayed IH; Eisele DW; Yom SS
Head Neck; 2018 May; 40(5):904-916. PubMed ID: 29210145
[TBL] [Abstract][Full Text] [Related]
12. Cancer of unknown primary: does treatment modality make a difference?
Balaker AE; Abemayor E; Elashoff D; St John MA
Laryngoscope; 2012 Jun; 122(6):1279-82. PubMed ID: 22538837
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive management of HPV-related squamous cell carcinoma of the head and neck of unknown primary.
Rassy E; Nicolai P; Pavlidis N
Head Neck; 2019 Oct; 41(10):3700-3711. PubMed ID: 31301162
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors for head and neck cancer of unknown primary including the impact of human papilloma virus infection.
Axelsson L; Nyman J; Haugen-Cange H; Bove M; Johansson L; De Lara S; Kovács A; Hammerlid E
J Otolaryngol Head Neck Surg; 2017 Jun; 46(1):45. PubMed ID: 28601094
[TBL] [Abstract][Full Text] [Related]
15. Contemporary management of lymph node metastases from an unknown primary to the neck: II. a review of therapeutic options.
Strojan P; Ferlito A; Langendijk JA; Corry J; Woolgar JA; Rinaldo A; Silver CE; Paleri V; Fagan JJ; Pellitteri PK; Haigentz M; Suárez C; Robbins KT; Rodrigo JP; Olsen KD; Hinni ML; Werner JA; Mondin V; Kowalski LP; Devaney KO; de Bree R; Takes RP; Wolf GT; Shaha AR; Genden EM; Barnes L
Head Neck; 2013 Feb; 35(2):286-93. PubMed ID: 22034062
[TBL] [Abstract][Full Text] [Related]
16. Oncologic outcomes of selective neck dissection in HPV-related oropharyngeal squamous cell carcinoma.
Zenga J; Jackson RS; Graboyes EM; Sinha P; Lindberg M; Martin EJ; Ma D; Thorstad WL; Rich JT; Moore EJ; Haughey BH
Laryngoscope; 2017 Mar; 127(3):623-630. PubMed ID: 27634021
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of bone or cartilage invasion of locally advanced head and neck cancers.
Do L; Syed N; Puthawala A; Azawi S; Williams R; Vora N
Am J Clin Oncol; 2010 Dec; 33(6):591-4. PubMed ID: 20065851
[TBL] [Abstract][Full Text] [Related]
18. Unknown primary squamous cell carcinoma of the head and neck: retrospective analysis of 80 cases.
Mizuta M; Kitamura M; Tateya I; Tamaki H; Tanaka S; Asato R; Shinohara S; Takebayashi S; Maetani T; Kitani Y; Kumabe Y; Kojima T; Ushiro K; Ichimaru K; Honda K; Yamada K; Omori K
Acta Otolaryngol; 2018 Jun; 138(6):590-596. PubMed ID: 29310489
[TBL] [Abstract][Full Text] [Related]
19. Inclusion of extracapsular spread in the pTNM classification system: a proposal for patients with head and neck carcinoma.
de Juan J; García J; López M; Orús C; Esteller E; Quer M; León X
JAMA Otolaryngol Head Neck Surg; 2013 May; 139(5):483-8. PubMed ID: 23681031
[TBL] [Abstract][Full Text] [Related]
20. Hypopharyngeal squamous cell carcinoma: Three-dimensional or Intensity-modulated radiotherapy? A single institution's experience.
Katsoulakis E; Riaz N; Hu M; Morris L; Sherman E; McBride S; Lee N
Laryngoscope; 2016 Mar; 126(3):620-6. PubMed ID: 26597398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
